Lisinopril and Hydrochlorothiazide
- Product NDC
- 0185-7100
- 11-digit product format
- 001857100
- Labeler code
- 0185
- Product ID
- 0185-7100_4e1b7662-d110-4334-9061-2474e1ae5bfb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Eon Labs, Inc.
- Application
- ANDA076262
- Marketing category
- ANDA
- Marketing start
- 2002-07-01
- Marketing end
- 2022-09-30
- Substance
- LISINOPRIL; HYDROCHLOROTHIAZIDE
- Active strength
- 10 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0185-7100-01 | 00185710001 | 100 TABLET in 1 BOTTLE (0185-7100-01) | 100 tablet | 2002-07-01 | 2022-07-31 | No | No | Current |
| 0185-7100-10 | 00185710010 | 1000 TABLET in 1 BOTTLE (0185-7100-10) | 1000 tablet | 2002-07-01 | 2021-06-30 | No | No | Current |